Congenital Heart Disease Clinical Trial
— SHTOfficial title:
The Impact of a Structured Lifestyle Intervention on Body Composition and Exercise Capacity in Overweight Children With Operated Heart Defects
Verified date | December 2016 |
Source | Western University, Canada |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Ethics Review Committee |
Study type | Interventional |
This study is to assess whether a lifestyle intervention with diet, exercise and counselling in young patients will have a positive influence on their weight and overall well-being. This study will enrol patients between the ages of 7 to 17 years of age, who have congenital heart disease, and have been identified being overweight or obese. A total of 40 individuals will participate in this study. The study duration will last for 1 year.
Status | Completed |
Enrollment | 40 |
Est. completion date | November 2016 |
Est. primary completion date | November 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 7 Years to 17 Years |
Eligibility |
Inclusion Criteria: - overweight or obese (BMI> 85%) patients - between 7-17 years of age - operated or non-operated congenital heart disease - reside in Southwestern Ontario Exclusion Criteria: - inability to comply with research testing or intervention components due to mental and/or physical disabilities, medications or comorbidities affecting weight or metabolic condition - involvement in any concurrent lifestyle intervention program |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Kambiz Norozi | London Health Sciences Centre |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Baseline Body Mass Index (BMI) at 1 year | BMI is derived from body mass divided by the square of the body height | This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame | No |
Primary | Change in Baseline Fat Mass at 1 year | Dual energy x-ray absorptiometry (DEXA) will measure fat mass. | This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame | No |
Primary | Change in Baseline Lean Mass at 1 year | Dual energy x-ray absorptiometry (DEXA) will measure lean mass. | This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame | No |
Primary | Change in Baseline Percent Fat at 1 year | Dual energy x-ray absorptiometry (DEXA) will measure percent fat. | This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame | No |
Primary | Change in Baseline Percent Android Fat at 1 year | Dual energy x-ray absorptiometry (DEXA) will measure percent android fat. | This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame | No |
Primary | Change in Baseline Visceral Adipose Tissue at 1 year | Dual energy x-ray absorptiometry (DEXA) will measure visceral adipose tissue. | This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame | No |
Primary | Change in Baseline Bone Mineral Content at 1 year | Dual energy x-ray absorptiometry (DEXA) will measure bone mineral content. | This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame | No |
Primary | Change in Baseline Maximum Oxygen Consumption at 1 year | Maximal exercise graded treadmill test will determine maximal oxygen consumption. | This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame | No |
Secondary | Change in Baseline Average Caloric Intake at 1 year | Average caloric intake is estimated from three-day food records. | This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame | No |
Secondary | Change in Baseline Self-Report Physical Activity Levels at 1 year | Physical activity levels will also be measured by the Physical Activity Questionnaire for Older Children | This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame | No |
Secondary | Change in Baseline Physical Activity Levels at 1 year | Physical activity levels will be measured from accelerometers | This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame | No |
Secondary | Change in Baseline Quality of Life at 1 year | Pediatric Quality of Life Inventory Generic Core Scales | This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame | No |
Secondary | Change in Baseline Muscle function at 1 year | Leonardo Mechanograph® Ground Reaction Force Plate will assess jumping height. | This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame | No |
Secondary | Change in Baseline Electrocardiographic measurement at 1 year | Electrocardiogram | This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame | No |
Secondary | Change in Baseline Transthoracic echocardiographic measurement at 1 year | Echo-cardiogram will be employed. | This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame | No |
Secondary | Change in Baseline Endothelial vasodilator function at 1 year | Peripheral arterial tonometry will assess endothelial vasodilator function. | This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame | No |
Secondary | Change in Baseline Lipid Profile at 1 year | Blood is drawn from patients who have been asked to fast for at least 10 hours. | This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame | No |
Secondary | Change in Baseline Electrolytes at 1 year | Blood is drawn from patients who have been asked to fast for at least 10 hours. | This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame | No |
Secondary | Change in Baseline Creatinine at 1 year | Blood is drawn from patients who have been asked to fast for at least 10 hours. | This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame | No |
Secondary | Change in Baseline Urea at 1 year | Blood is drawn from patients who have been asked to fast for at least 10 hours. | This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame | No |
Secondary | Change in Baseline Fasting Glucose at 1 year | Blood is drawn from patients who have been asked to fast for at least 10 hours. | This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame | No |
Secondary | Change in Baseline Serum Insulin at 1 year | Blood is drawn from patients who have been asked to fast for at least 10 hours. | This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame | No |
Secondary | Change in Baseline Adiponectin at 1 year | Blood is drawn from patients who have been asked to fast for at least 10 hours. | This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04992793 -
Paediatric Brain Injury Following Cardiac Interventions
|
||
Recruiting |
NCT05213598 -
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
|
||
Completed |
NCT04136379 -
Comparison of Home and Standard Clinic Monitoring of INR in Patients With CHD
|
||
Completed |
NCT04814888 -
3D Airway Model for Pediatric Patients
|
||
Recruiting |
NCT04920643 -
High-exchange ULTrafiltration to Enhance Recovery After Pediatric Cardiac Surgery
|
N/A | |
Completed |
NCT05934578 -
Lymphatic Function in Patients With Fontan Circulation: Effect of Physical Training
|
N/A | |
Recruiting |
NCT06041685 -
Effect of Local Warming for Arterial Catheterization in Pediatric Anesthesia
|
N/A | |
Recruiting |
NCT05902013 -
Video Laryngoscopy Versus Direct Laryngoscopy for Nasotracheal Intubation
|
N/A | |
Not yet recruiting |
NCT05687292 -
Application of a Clinical Decision Support System to Reduce Mechanical Ventilation Duration After Cardiac Surgery
|
||
Not yet recruiting |
NCT05524324 -
Cardiac Resynchronization Therapy in Adult Congenital Heart Disease With Systemic Right Ventricle: RIGHT-CRT
|
N/A | |
Completed |
NCT02746029 -
Cardiac Murmurs in Children: Predictive Value of Cardiac Markers
|
||
Completed |
NCT02537392 -
Multi-micronutrient Supplementation During Peri-conception and Congenital Heart Disease
|
N/A | |
Completed |
NCT03119090 -
Fontan Imaging Biomarkers (FIB) Study
|
||
Recruiting |
NCT02258724 -
Swiss National Registry of Grown up Congenital Heart Disease Patients
|
||
Terminated |
NCT02046135 -
Sodium Bicarbonate to Prevent Acute Kidney Injury in Children Undergoing Cardiac Surgery
|
Phase 2 | |
Completed |
NCT01966237 -
Milrinone Pharmacokinetics and Acute Kidney Injury
|
||
Recruiting |
NCT01184404 -
Bosentan Improves Clinical Outcome of Adults With Congenital Heart Disease or Mitral Valve Lesions Who Undergo CArdiac Surgery
|
N/A | |
Completed |
NCT01548950 -
Drug Therapy and Surgery in Congenital Heart Disease With Pulmonary Hypertension
|
N/A | |
Completed |
NCT01178710 -
Effect of Simvastatin on Cardiac Function
|
N/A |